Clinical trial / 2013
Systemic lycopene improved periodontal indices and salivary inflammatory markers in chronic periodontitis.
A randomized, double-blind trial assigned 42 adults with chronic periodontitis to receive scaling and root planing with either 8 mg lycopene daily (n = 21) or placebo (n = 21) for two months. Compared to placebo, the lycopene group had significantly greater improvements in plaque index (P = .004), modified gingival index (P = .002), bleeding on probing (P = .021), salivary interleukin-1beta (P = .05), and uric acid (P = .02). Clinical attachment gain, probing pocket depth reduction, and serum TNF-alpha did not differ significantly.
- Study type
- Randomized controlled trial
- Who was studied
- 42 adults with chronic periodontitis
- What was measured
- Periodontal clinical parameters and inflammatory markers
THE PAPER
The adjunctive use of systemic antioxidant therapy (lycopene) in nonsurgical treatment of chronic periodontitis: a short-term evaluation.
Arora N, Avula H, Avula JK. Quintessence Int, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.